A systematic review of biomarkers for disease progression in Parkinson’s disease

BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McGhee, David JM, Royle, Pamela L, Thompson, Paul A, Wright, David E, Zajicek, John P, Counsell, Carl E
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637496/
https://ncbi.nlm.nih.gov/pubmed/23587062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-35
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars